• OPEN AN ACCOUNT
Indian Indices
Sensex
76,277.97 -666.31
( -0.87%)
Global Indices
Nasdaq
52,794.59 -412.31
(-0.77%)
Dow Jones
7,653.60 -53.54
(-0.69%)
Hang Seng
66,431.13 119.20
(0.18%)
Nikkei 225
10,792.77 -31.49
(-0.29%)
Forex
USD-INR
95.24 -0.24
(-0.25%)
EUR-INR
110.49 -0.08
(-0.07%)
GBP-INR
128.99 -0.20
(-0.15%)
JPY-INR
0.60 0.00
(-0.03%)

EQUITY - MARKET SCREENER

Titan Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524717
INE150C01029
41.3479918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
53.1
1632.49
EPS(TTM)
Face Value()
Div & Yield %
7.44
2
0.13
 

Tata Investment Corporation consolidated net profit rises 69.22% in the March 2026 quarter
Apr 22,2026
Net profit of Tata Investment Corporation rose 69.22% to Rs 63.83 crore in the quarter ended March 2026 as against Rs 37.72 crore during the previous quarter ended March 2025. Sales rose 143.34% to Rs 39.98 crore in the quarter ended March 2026 as against Rs 16.43 crore during the previous quarter ended March 2025.

For the full year,net profit rose 38.96% to Rs 433.68 crore in the year ended March 2026 as against Rs 312.09 crore during the previous year ended March 2025. Sales rose 30.24% to Rs 397.34 crore in the year ended March 2026 as against Rs 305.08 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales39.9816.43 143 397.34305.08 30
OPM %74.0144.98 -89.4287.26 -
PBDT58.8936.73 60 477.97370.13 29
PBT57.9335.81 62 474.08368.47 29
NP63.8337.72 69 433.68312.09 39